Please wait a minute...
Search Asian J Urol Advanced Search
Share 
Asian Journal of Urology, 2023, 10(4): 526-533    doi: 10.1016/j.ajur.2021.12.002
  本期目录 | 过刊浏览 | 高级检索 |
Gender differences of lower urinary tract symptoms in older Chinese Americans
Tsung Moua*(),Oluwateniola Browna,Yingxiao Huab,Melissa Simonc,XinQi Dongb,Kimberly Kentona,C. Emi Bretschneidera
aDivision of Female Pelvic Medicine and Reconstructive Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
bInstitute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ, USA
cDepartment of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
下载:  HTML  PDF (478KB) 
输出:  BibTeX | EndNote (RIS)      
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
Abstract: 

Objective: To describe whether or not there are gender differences in lower urinary tract symptoms (LUTS) prevalence and risk factors in community-dwelling older Chinese Americans.

Methods: We performed a secondary analysis of a prospective cross-sectional population-based survey of Chinese Americans aged 60 years and older between January 2011 and December 2013 in English, Mandarin, Cantonese, Taishanese, or Teochew. A clinical review of systems was used to assess LUTS, which included urinary frequency, urgency, burning and/or pain, blood in urine, and urinary incontinence.

Results: Of the total 3157 people queried, 42% were men and 58% were women. More men reported LUTS compared to women (32.9% vs. 28.6%, p=0.01). In a multivariable analysis, female gender (adjusted odds ratio [aOR] 0.60, 95% confidence interval [CI] 0.49-0.73), being married (aOR 0.79, 95% CI 0.65-0.97), and smoking (aOR 0.66, 95% CI 0.49-0.88) were found to be protective, while traditional Chinese medicine use (aOR 1.51, 95% CI 1.28-1.78), heart disease (aOR 1.54, 95% CI 1.24-1.91), and anxiety (aOR 1.69, 95% CI 1.25-2.28) were most strongly associated with increased odds of LUTS. When examining genders separately, being married was found to be protective only in women. Meanwhile, unique factors found in men were hypertension, heart disease, and practice of Tai Chi.

Conclusion: In this large population-based study, LUTS were more prevalent in older Chinese American men than women. We also found gender-specific factors that influenced the odds of reporting LUTS; however, traditional Chinese medicine use was the only factor that was shared by both genders. Future longitudinal investigations are needed to elucidate these underlying mechanisms to provide evidence-based and culture-specific guidelines for this rapidly growing population.

Key words:  Chinese American    Lower urinary tract symptom    Gender    Prevalence    Risk factor
收稿日期:  2021-03-10      修回日期:  2021-06-07      接受日期:  2021-07-14      出版日期:  2023-10-20      发布日期:  2023-11-13      整期出版日期:  2023-10-20
引用本文:    
. [J]. Asian Journal of Urology, 2023, 10(4): 526-533.
Tsung Mou, Oluwateniola Brown, Yingxiao Hua, Melissa Simon, XinQi Dong, Kimberly Kenton, C. Emi Bretschneider. Gender differences of lower urinary tract symptoms in older Chinese Americans. Asian Journal of Urology, 2023, 10(4): 526-533.
链接本文:  
http://www.ajurology.com/CN/10.1016/j.ajur.2021.12.002  或          http://www.ajurology.com/CN/Y2023/V10/I4/526
Demographic and LUTS Men
(
n=1328)
Women
(
n=1829)
p-Value
Age, mean±SD, year 72.8±7.9 72.9±8.6 0.69
Education, mean±SD, year 9.9±4.8 7.9±5.1 <0.001
Years in the US, mean±SD 19.5±13.5 20.4±12.9 0.07
Married, n (%) 1178 (88.8) 1058 (58.0) <0.001
Income level (per year), n (%) <0.001
$0–$4999 486 (37.0) 554 (30.6)
$5000–$9999 631 (48.1) 985 (54.5)
$10 000 and above 196 (14.9) 269 (14.9)
LUTS, n (%)
Any LUTS 437 (32.9) 524 (28.6) 0.01
Frequency 370 (27.9) 409 (22.4) 0.004
Urgency 219 (16.5) 230 (12.6) 0.002
Burning or pain 38 (2.9) 41 (2.2) 0.21
Hematuria 20 (1.5) 31 (1.7) 0.66
Incontinence 38 (2.9) 102 (5.6) 0.003
OAB-dry 382 (28.8) 388 (21.2) <0.001
  
Characteristic and comorbidity LUTS OAB-dry symptom
Men without LUTS (n=891) Men with LUTS (n=437) p-Value Men without OAB-drya (n=946) Men with OAB-drya (n=382) p-Value
Age, mean±SD, year 71.9±8.0 74.4±7.4 <0.001 72.2±8.1 74.1±7.4 <0.001
BMI, mean±SD, kg/m2 23.0±3.3 23.5±3.3 0.01 23.0±3.4 23.5±3.1 0.02
Education, mean±SD, year 9.6±4.7 10.6±4.8 <0.001 9.7±4.8 10.5±4.8 0.004
Married, n (%) 801 (90.1) 377 (86.3) 0.04 845 (89.5) 333 (87.2) 0.22
Current smoker, n (%) 260 (29.2) 76 (17.4) <0.001 268 (28.4) 68 (17.8) <0.001
Alcohol use, n (%) 0.10 0.18
Never 661 (74.3) 327 (74.8) 702 (74.3) 286 (74.9)
Monthly or less 122 (13.7) 76 (17.4) 132 (14.0) 66 (17.3)
2-4 times a month 31 (3.5) 9 (2.1) 32 (3.4) 8 (2.1)
2-3 times a week 13 (1.5) 5 (1.1) 13 (1.4) 5 (1.3)
4 times or more a week 63 (7.1) 20 (4.6) 66 (7.0) 17 (4.5)
TCM herb userb, n (%) 258 (29.0) 163 (37.3) 0.002 276 (29.2) 145 (38.0) 0.002
Tai Chi userc, n (%) 71 (8.0) 63 (14.4) <0.001 78 (8.2) 56 (14.7) 0.001
Cognitive mental statusd, n (%) 0.40 0.31
Severely impaired 6 (0.7) 7 (1.6) 8 (0.9) 5 (1.3)
Moderately impaired 33 (3.8) 16 (3.8) 40 (4.3) 9 (2.4)
Mildly impaired 99 (11.3) 52 (12.2) 104 (11.2) 47 (12.5)
Not impaired 738 (84.2) 351 (82.4) 774 (83.6) 315 (83.8)
NAGI scoree, mean±SD 1.9±3.1 3.1±4.0 <0.001 2.1±3.4 2.8±3.5 <0.001
ADL scoref, mean±SD 0.2±1.1 0.6±3.0 <0.001 0.3±1.9 0.3±1.9 0.29
Comorbidity, n (%)
Anxietyg 31 (3.5) 38 (8.9) <0.001 40 (4.3) 29 (7.7) 0.01
Depressionh 126 (14.2) 87 (20.2) 0.01 146 (15.5) 67 (17.8) 0.31
Heart disease 109 (12.2) 120 (27.5) <0.001 127 (13.4) 102 (26.7) <0.001
Stroke 47 (5.3) 49 (11.2) <0.001 59 (6.2) 37 (9.7) 0.03
Any cancer 32 (3.6) 27 (6.2) 0.03 37 (3.9) 22 (5.8) 0.14
Diabetes 171 (19.3) 119 (27.2) 0.001 192 (20.4) 98 (25.7) 0.03
Hypertension 420 (47.2) 271 (62.2) <0.001 449 (47.5) 242 (63.5) <0.001
Osteoarthritis 233 (26.2) 163 (37.3) <0.001 255 (27.0) 141 (36.9) <0.001
  
Characteristic and comorbidity LUTS OAB-dry symptom
Women without LUTS (n=1305) Women with LUTS
(
n=524)
p-Value Women without OAB-drya (n=1441) Women with OAB-drya (n=388) p-Value
Age mean±SD, year 72.1±8.4 74.7±8.7 <0.001 72.6±8.7 73.9±8.2 0.01
BMI, mean±SD, kg/m2 23.1±3.4 23.4±3.7 0.18 23.1±3.5 23.4±3.7 0.25
Education, mean±SD, year 7.8±5.0 8.0±5.2 0.42 7.8±5.1 7.9±5.1 0.81
Married, n (%) 797 (61.3) 261 (49.8) <0.001 861 (59.5) 197 (50.8) 0.001
Current smoker, n (%) 12 (0.9) 2 (0.4) 0.23 12 (0.8) 2 (0.5) 0.52
Alcohol use, n (%) 0.18 0.34
Never 1214 (93.0) 496 (94.7) 1340 (93.0) 370 (95.4)
Monthly or less 66 (5.1) 20 (3.8) 72 (5.0) 14 (3.6)
2-4 times a month 9 (0.7) 6 (1.1) 12 (0.8) 3 (0.8)
2-3 times a week 6 (0.5) 2 (0.4) 7 (0.5) 1 (0.3)
4 times or more a week 10 (0.8) 0 (0) 10 (0.7) 0 (0)
TCM herb userb, n (%) 466 (35.7) 263 (50.2) <0.001 534 (37.1) 195 (50.3) <0.001
Tai Chi userc, n (%) 137 (10.5) 66 (12.6) 0.20 152 (10.5) 51 (13.1) 0.14
Cognitive mental statusd, n (%) 0.003 0.06
Severely impaired 17 (1.4) 13 (2.6) 27 (2.0) 3 (0.8)
Moderately impaired 124 (9.9) 65 (13.1) 143 (10.4) 46 (12.5)
Mildly impaired 201 (16.1) 100 (20.2) 225 (16.3) 76 (20.6)
Not impaired 909 (72.7) 317 (64.0) 982 (71.3) 244 (66.1)
NAGI scoree, mean±SD 3.3±4.0 5.3±4.8 <0.001 3.6±4.2 4.8±4.5 <0.001
ADL scoref, mean±SD 0.3±1.7 0.8±3.2 <0.001 0.5±2.4 0.4±1.7 0.39
Comorbidity, n (%)
Anxietyg 108 (8.4) 88 (16.9) <0.001 135 (9.5) 61 (15.8) <0.001
Depressionh 241 (18.6) 185 (35.4) <0.001 298 (20.8) 128 (33.0) <0.001
Heart disease 156 (12.0) 93 (17.8) 0.001 183 (12.7) 66 (17.0) 0.03
Stroke 45 (3.5) 40 (7.6) <0.001 56 (3.9) 29 (7.5) 0.002
Any cancer 68 (5.2) 39 (7.4) 0.07 83 (5.8) 24 (6.2) 0.75
Diabetes 270 (20.7) 143 (27.3) 0.002 309 (21.5) 104 (26.9) 0.02
Hypertension 721 (55.3) 327 (62.6) 0.004 804 (55.8) 244 (63.2) 0.01
Osteoarthritis 552 (42.4) 283 (54.0) <0.001 636 (44.2) 199 (51.3) 0.01
  
Perception of health and life quality Any LUTS OAB-dry symptom
Men Women p-Value Men Women p-Value
General health perceptiona, n (%) 0.01 0.03
Very good 16 (3.7) 6 (1.1) 14 (3.7) 5 (1.3)
Good 101 (23.1) 110 (21.0) 89 (23.3) 89 (22.9)
Fair 211 (48.3) 243 (46.4) 194 (50.8) 181 (46.7)
Poor 109 (24.9) 165 (31.5) 85 (22.3) 113 (29.1)
Quality of lifeb, n (%) 0.44 0.70
Very good 33 (7.6) 1 (0.2) 29 (7.6) 26 (6.7)
Good 155 (35.5) 43 (9.3) 136 (35.6) 153 (39.4)
Fair 231 (52.9) 192 (41.7) 202 (52.9) 193 (49.7)
Poor 18 (4.1) 224 (48.7) 15 (3.9) 16 (4.1)
  
Clinical characteristic Any LUTS OAB-dry symptom
Total Men Women Total Men Women
Female 0.60 (0.49-0.73) 0.52 (0.42-0.63)
Age 1.02 (1.01-1.03) 1.03 (1.01-1.04) 1.02 (1.00-1.03) 1.01 (1.00-1.02) 1.02 (1.00-1.04) 1.00 (0.99-1.02)
BMI 1.02 (0.99-1.04) 1.02 (0.98-1.06) 1.02 (0.99-1.05) 1.01 (0.99-1.04) 1.01 (0.97-1.05) 1.02 (0.98-1.05)
Education 1.03 (1.01-1.05) 1.03 (1.01-1.06) 1.03 (1.00-1.05) 1.02 (0.99-1.04) 1.02 (0.99-1.05) 1.01 (0.99-1.04)
Married 0.79 (0.65-0.97) 0.84 (0.57-1.24) 0.75 (0.59-0.96) 0.93 (0.62-1.34) 0.94 (0.63-1.40) 0.73 (0.56-0.94)
Current smoker 0.66 (0.49-0.88) 0.73 (0.54-1.00) 0.33 (0.07-1.56) 0.67 (0.49-0.90) 0.72 (0.52-0.99) 0.54 (0.12-2.50)
NAGI scorea 1.06 (1.04-1.09) 1.08 (1.04-1.12) 1.06 (1.03-1.09) 1.03 (1.00-1.05) 1.03 (0.99-1.07) 1.02 (0.99-1.06)
TCM herb user 1.51 (1.28-1.78) 1.33 (1.02-1.73) 1.62 (1.30-2.02) 1.51 (1.26-1.80) 1.39 (1.06-1.81) 1.60 (1.26-2.03)
Practice of Tai Chi 1.35 (1.05-1.74) 1.78 (1.21-2.62) 1.14 (0.81-1.61) 1.39 (1.07-1.81) 1.66 (1.13-2.45) 1.24 (0.86-1.79)
Hypertension 1.23 (1.04-1.46) 1.37 (1.05-1.78) 1.11 (0.88-1.40) 1.35 (1.13-1.63) 1.52 (1.16-1.98) 1.20 (0.93-1.54)
Heart disease 1.54 (1.24-1.91) 1.91 (1.39-2.61) 1.23 (0.91-1.67) 1.47 (1.18-1.84) 1.78 (1.30-2.45) 1.18 (0.85-1.63)
Anxiety 1.69 (1.25-2.28) 2.74 (1.54-4.87) 1.36 (0.96-1.95) 1.47 (1.08-2.01) 1.91 (1.08-3.39) 1.27 (0.87-1.85)
Depression 1.34 (1.07-1.68) 0.93 (0.64-1.36) 1.70 (1.28-2.26) 1.22 (0.96-1.55) 0.88 (0.60-1.30) 1.55 (1.14-2.11)
  
[1] Irwin DE, Milsom I, Kopp Z, Abrams P, Cardozo L. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int 2006; 97:96-100.
pmid: 16336336
[2] Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT Study. J Clin Epidemiol 2000; 53:1150-7.
doi: 10.1016/s0895-4356(00)00232-8 pmid: 11106889
[3] Coyne KS, Margolis MK, Kopp ZS, Kaplan SA. Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study. J Urol 2012; 79: 95-101.
[4] Hoeffel EM, Rastogi S, Kim MO, Hasan S. The Asian population; 2010. https://www.census.gov/prod/cen2010/briefs/c2010br-11.pdf. [Accessed 09 March 2021].
[5] Finkelstein K, Glosner S, Sanchez RJ, Uddin N. Prevalence of probable overactive bladder in a private obstetrics and gynecology group practice. Curr Med Res Opin 2008; 24:1083-90.
doi: 10.1185/030079908X280644 pmid: 18328119
[6] Anger JT, Saigal CS, Litwin MS; Urologic Diseases of America Project. The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol 2006; 175: 601-4.
doi: 10.1016/S0022-5347(05)00242-9 pmid: 16407004
[7] Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20:327-36.
doi: 10.1007/s00345-002-0301-4 pmid: 12811491
[8] Budiman A, Ruiz NG. Key facts about Asian Americans, a diverse and growing population. https://www.pewresearch.org/fact-tank/2017/09/08/key-facts-about-asian-americans/. [Accessed 09 March 2021].
[9] US Census Bureau. Asian-American and Pacific Islander heritage month. https://www.census.gov/newsroom/facts-forfeatures/2018/asian-american.html. [Accessed 09 March 2021].
[10] Wang Y, Hu H, Xu K, Wang X, Na Y, Kang X. Prevalence, risk factors and the bother of lower urinary tract symptoms in China: a population-based survey. Int Urogynecol J 2015; 26:911-9.
doi: 10.1007/s00192-015-2626-8 pmid: 25653032
[11] Wong SY, Woo J, Hong A, Leung JC, Kwok T, Leung PC. Risk factors for lower urinary tract symptoms in southern Chinese men. J Urol 2006; 68:1009-14.
[12] Gao Y, Wang M, Zhang H, Tan A, Yang X, Qin X, et al. Are metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population survey. J Urol 2012; 79:194-201.
[13] Zhang W, Song Y, He X, Xu B, Huang H, He C, et al. Prevalence and risk factors of lower urinary tract symptoms in Fuzhou Chinese women. Eur Urol 2005; 48:309-13.
pmid: 16005377
[14] Dong X, Wong E, Simon MA. Study design and implementation of the PINE study. J Aging Health 2014; 26:1085-99.
doi: 10.1177/0898264314526620 pmid: 24667107
[15] Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 2011; 108:1132-8.
doi: 10.1111/j.1464-410X.2010.09993.x pmid: 21231991
[16] Leung CM, Ho S, Kan CS, Hung CH, Chen CN. Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale: a cross-cultural perspective. Int J Psychosom 1993; 40:29-34.
[17] Li H, Jia J, Yang Z. Mini-mental state examination in elderly Chinese: a population-based normative study. J Alzheim Dis 2016; 53:487-96.
doi: 10.3233/JAD-160119
[18] Tong AYC, David WKM. The validation of the Hong Kong Chinese version of the lawton instrumental activities of daily living Scale for institutionalized elderly persons. Occup Ther J Res (Thorofare N J) 2002; 22:132-42.
[19] Li L, Wang HM, Shen Y. Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health 2003; 57:259-63.
doi: 10.1136/jech.57.4.259
[20] Lyons RA, Perry HM, Littlepage BN. Evidence for the validity of the Short-form 36 Questionnaire (SF-36) in an elderly population. Age Ageing 1994; 23:182-4.
pmid: 8085500
[21] Lam CL, Gandek B, Ren XS, Chan MS. Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey. J Clin Epidemiol 1998; 51:1139-47.
doi: 10.1016/s0895-4356(98)00105-x pmid: 9817131
[22] Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep 2008;(12):1-23.
[23] Kaptchuk TJ. The web that has no weaver: understanding Chinese medicine. Philos East W 1986; 36:67-8.
[24] Alraek T, Aune A, Baerheim A. Traditional Chinese medicine syndromes in women with frequently recurring cystitis: frequencies of syndromes and symptoms. Compl Ther Med 2000; 8:260-5.
doi: 10.1054/ctim.2000.0399
[25] Chughtai B, Kavaler E, Lee R, Te A, Kaplan SA, Lowe F. Use of herbal supplements for overactive bladder. Rev Urol 2013; 15: 93-6.
pmid: 24223020
[26] Coyne KS, Kaplan SA, Chapple CR, Sexton CC, Kopp ZS, Bush EN, et al. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int 2009; 103(Suppl. 3):24-32. https://doi.org/10.1111/j.1464-410X.2009.08438.x.
[27] Litman HJ, Steers WD, Wei JT, Kupelian V, Link CL, McKinlay JB, et al. Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston Area Community Health survey. Urology 2007; 70:916-21.
[28] Kiecolt-Glaser JK, Newton TL. Marriage and health: his and hers. Psychol Bull 2001; 127:472-503.
doi: 10.1037/0033-2909.127.4.472 pmid: 11439708
[29] Sugaya K, Kadekawa K, Ikehara A, Nakayama T, Gakiya M, Nashiro F, et al. Influence of hypertension on lower urinary tract symptoms in benign prostatic hyperplasia. Int J Urol 2003; 10:569-75.
pmid: 14633079
[30] Lu WA, Kuo CD. The effect of Tai Chi Chuan on the autonomic nervous modulation in older persons. Med Sci Sports Exerc 2003; 35:1972-6.
doi: 10.1249/01.MSS.0000099242.10669.F7
[31] Chang RY, Koo M, Yu ZR, Kan CB, Chu IT, Hsu CT, et al. The effect of t’ai chi exercise on autonomic nervous function of patients with coronary artery disease. J Alternative Compl Med 2008; 14:1107-13.
[32] Jung S, Lee EN, Lee SR, Kim MS, Lee MS. Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomized controlled trial. Evid base Compl Alternative Med 2012; 2012:624692. https://doi.org/10.1155/2012/624692.
No related articles found!
[1] Ponco Birowo,Nur Rasyid,Chaidir A. Mochtar,Bambang S. Noegroho,H.R. Danarto,Besut Daryanto,Lukman Hakim,Dyandra Parikesit,Fakhri Rahman,S. Cahyo Ariwicaksono. Daily activities and training experiences of urology residents during the coronavirus disease 2019 pandemic in Indonesia: A nationwide survey[J]. Asian Journal of Urology, 2023, 10(2): 119 -127 .
[2] Saeed R. Khan,Benjamin K. Canales. Proposal for pathogenesis-based treatment options to reduce calcium oxalate stone recurrence[J]. Asian Journal of Urology, 2023, 10(3): 246 -257 .
[3] Guohua Zeng,Wei Zhu. Urolithiasis: From pathogenesis to management (part one)[J]. Asian Journal of Urology, 2023, 10(3): 213 -214 .
[4] Rasim Güzel,Ümit Yildirim,Kemal Sarica. Contemporary minimal invasive surgical management of stones in children[J]. Asian Journal of Urology, 2023, 10(3): 239 -245 .
[5] Lazaros Tzelves,Patrick Juliebø-Jones,Ioannis Manolitsis,Themistoklis Bellos,Ioannis Mykoniatis,Marinos Berdempes,Titos Markopoulos,Michael Lardas,Belthangady M. Zeeshan Hameed,Panagiotis Angelopoulos,Amelia Pietropaolo,Bhaskar Somani,Ioannis Varkarakis,Andreas Skolarikos. Radiation protection measures during endourological therapies[J]. Asian Journal of Urology, 2023, 10(3): 215 -225 .
[6] Giorgio Mazzon,Simon Choong,Antonio Celia. Stone-scoring systems for predicting complications in percutaneous nephrolithotomy: A systematic review of the literature[J]. Asian Journal of Urology, 2023, 10(3): 226 -238 .
[7] Anastasios Anastasiadis,Antonios Koudonas,Georgios Langas,Stavros Tsiakaras,Dimitrios Memmos,Ioannis Mykoniatis,Evangelos N. Symeonidis,Dimitrios Tsiptsios,Eliophotos Savvides,Ioannis Vakalopoulos,Georgios Dimitriadis,Jean de la Rosette. Transforming urinary stone disease management by artificial intelligence-based methods: A comprehensive review[J]. Asian Journal of Urology, 2023, 10(3): 258 -274 .
[8] Reza Mehrazin, Shirin Razdan. Utility of three-dimensional virtual reconstruction for robotic-assisted partial nephrectomy using the IRIS[J]. Asian Journal of Urology, 2023, 10(4): 388 -389 .
[9] Savio Domenico Pandolfo, Clara Cerrato, Zhenjie Wu, Antonio Franco, Francesco Del Giudice, Alessandro Sciarra, Paolo Verze, Giuseppe Lucarelli, Ciro Imbimbo, Sisto Perdonà, Edward E. Cherullo, Francesco Porpiglia, Ithaar H. Derweesh, Riccardo Autorino. A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors[J]. Asian Journal of Urology, 2023, 10(4): 390 -406 .
[10] Enrico Checcucci, Alberto Piana, Gabriele Volpi, Pietro Piazzolla, Daniele Amparore, Sabrina De Cillis, Federico Piramide, Cecilia Gatti, Ilaria Stura, Enrico Bollito, Federica Massa, Michele Di Dio, Cristian Fiori, Francesco Porpiglia. Three-dimensional automatic artificial intelligence driven augmented-reality selective biopsy during nerve-sparing robot-assisted radical prostatectomy: A feasibility and accuracy study[J]. Asian Journal of Urology, 2023, 10(4): 407 -415 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed